Expression of hsp90 and cyclin D1 in human breast cancer.
about
Heat shock protein-90-alpha, a prolactin-STAT5 target gene identified in breast cancer cells, is involved in apoptosis regulationUpregulation of Hsp90-beta and annexin A1 correlates with poor survival and lymphatic metastasis in lung cancer patientsDiscovery and validation of small-molecule heat-shock protein 90 inhibitors through multimodality molecular imaging in living subjectsDirect activation of HSP90A transcription by c-Myc contributes to c-Myc-induced transformationHeat shock protein expression in canine malignant mammary tumours.Heat shock protein90 in lobular neoplasia of the breast.Hsp90 in the continuum of breast ductal carcinogenesis: Evaluation in precursors, preinvasive and ductal carcinoma lesionsDecreased Hsp90 expression in infiltrative lobular carcinoma: an immunohistochemical study.Expression of cell cycle proteins in male breast carcinoma.Differential heat shock protein localization in chronic lymphocytic leukemiaExpression of heat shock proteins and heat shock protein messenger ribonucleic acid in human prostate carcinoma in vitro and in tumors in vivo.Geldanamycin and Its Derivatives Inhibit the Growth of Myeloma Cells and Reduce the Expression of the MET Receptor.Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implicationsChaperones in cell cycle regulation and mitogenic signal transduction: a review.Molecular imaging of the efficacy of heat shock protein 90 inhibitors in living subjects.Identification and verification of Hsp90-beta as a potential serum biomarker for lung cancer.HSP90 Inhibitor Geldanamycin as a Radiation Response Modificator in Human Blood CellsHSP90: a rising star on the horizon of anticancer targets.Heat shock proteins in animal neoplasms and human tumours--a comparisonA phase II study of 17-allylamino-17-demethoxygeldanamycin in metastatic or locally advanced, unresectable breast cancerThe significance of heat shock proteins in breast cancer therapy.Analysis of expression of heat shock protein-90 (HSP90) and the effects of HSP90 inhibitor (17-AAG) in multiple myeloma.2-phenylethynesulphonamide (PFT-μ) enhances the anticancer effect of the novel hsp90 inhibitor NVP-AUY922 in melanoma, by reducing GSH levels.Can the lack of HSP90alpha protein in brain normal tissue and cell lines, rationalise it as a possible therapeutic target for gliomas?Expression of a dominant negative heat shock factor-1 construct inhibits aneuploidy in prostate carcinoma cells.Induction of Hsp90 protein expression in malignant melanomas and melanoma metastases.Identification of Src transformation fingerprint in human colon cancer.Elevated levels of ribosomal proteins eL36 and eL42 control expression of Hsp90 in rhabdomyosarcoma.Heat shock protein 90 (hsp90) expression and breast cancer.Involvement of HSP10 during the ovarian follicular development of polycystic ovary syndrome: Study in both human ovaries and cultured mouse follicles.Ganetespib targets multiple levels of the receptor tyrosine kinase signaling cascade and preferentially inhibits ErbB2-overexpressing breast cancer cells.Oligosaccharides from human milk influence growth-related characteristics of intestinally transformed and non-transformed intestinal cells.Down-regulated expression of HSP70 in correlation with clinicopathology of cholangiocarcinoma.
P2860
Q21195216-40572B2F-BCB5-4EB1-BFC4-4222D5A48246Q21198841-64B77F0C-E635-4B5B-ADA5-F1F1D77D4E3BQ24600166-34E5F569-CFBF-41F9-83DB-5D114FA98B10Q28238796-8F96611D-688C-49C9-A8C6-B1162E55B249Q33248080-086C8831-EA2F-4856-91A6-82E27B72771BQ33379951-D19F1CC9-CC55-4244-920E-FBEC391F1012Q33625453-33B71D39-C057-4B1C-9310-38C6E4553CF5Q33651638-2767E75D-EC12-4860-8DA2-7D3DAE946A51Q33692284-8B37F59C-893E-4EFD-BBBB-6D25C6AD4DBDQ33694521-E8496FB4-2524-46AD-8DAA-29B02F3FF3AEQ33736465-CB1AA338-5889-4300-98F8-3A32D1DEFDCEQ33789416-09F84701-957E-4348-8340-B9CB31D99075Q33899708-BF9EFD0C-7B6B-42EF-98DC-F929F776E6FCQ34095732-4355CD27-4481-4F6C-BE12-8EE8ACE6C128Q34096497-FCE7A4FB-750D-447F-B22D-66B57180C30EQ34704972-C95E256F-D17E-48AC-A2A1-87442F61B16EQ36358976-B9EE2C25-31C6-4803-9464-E6A9AD71500DQ36429542-DEC47495-3C4D-4BD0-BCCC-B9A541FE7CCBQ37107963-39EABC5E-5577-426F-85BD-A93AF36BE026Q37338986-ADD5D1CD-87E7-4E31-9DA6-3F9ECC4B39E2Q38100745-A6F5A9C3-F700-4C09-8371-B5E03CB0C0C3Q38436359-CB4A69A9-A395-4F9C-8725-D2E633F3F2FBQ38785352-88E3C9E1-F82C-4E52-BA8C-448EFE53842FQ39938926-A68A936E-A547-4C96-804C-9BA48AA4B308Q40554094-73ECA25C-0801-4D88-90B7-D075E1E8FE2CQ40580807-B3D39EDA-C733-4378-AE06-7BA7D4BF3A03Q40698849-49CA050A-306F-4BB0-82FF-7A511E14F0C2Q42346113-2387B6CF-22C0-4ADE-8101-923F7EBEFBB8Q42922811-F9047968-BEEC-4B09-B524-144CF5E2D026Q43244969-24C34C9F-1710-4962-BD55-0222C8D40BBEQ52714930-8C86B199-300F-47A5-931D-FF97BBF32380Q53328267-855A47A2-2D52-40B2-8501-B4A830C0D190Q54359831-12ECB2E8-1A54-4A87-A597-A2E26757E9FE
P2860
Expression of hsp90 and cyclin D1 in human breast cancer.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Expression of hsp90 and cyclin D1 in human breast cancer.
@ast
Expression of hsp90 and cyclin D1 in human breast cancer.
@en
type
label
Expression of hsp90 and cyclin D1 in human breast cancer.
@ast
Expression of hsp90 and cyclin D1 in human breast cancer.
@en
prefLabel
Expression of hsp90 and cyclin D1 in human breast cancer.
@ast
Expression of hsp90 and cyclin D1 in human breast cancer.
@en
P2093
P1433
P1476
Expression of hsp90 and cyclin D1 in human breast cancer.
@en
P2093
Inokuchi M
Ishiwata T
Yokoyama M
P356
10.1016/S0304-3835(98)00338-3
P407
P577
1999-03-01T00:00:00Z